Author

Anurag Majumdar

The University of Texas MD Anderson Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Abhinav K. JainiD· 1 shared Ádám KepecsiD· 1 shared Aminah J. Tannir· 1 shared Bidisha ChakrabortyiD· 1 shared Brian A. KleiboekeriD· 1 shared Brian S. LearmaniD· 1 shared Byron Hing Lung LeeiD· 1 shared Clara T. KimiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Abhinav K. JainORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PhysiologyNature MetabolismPeer-reviewedJan 8, 2026

Central activation of catecholamine-independent lipolysis drives the end-stage catabolism of all adipose tissues

Xiao Zhang, Sreejith S. Panicker, Jordan M. Bollinger…·Erica L. Scheller

The paper identifies a catecholamine-independent lipolysis pathway activated by hypoglycemia and hypoinsulinemia that enables catabolism of stable adipose tissues.

9 citationstop 1%

mouseexperimental assay

𝕏 PostBluesky

ImmunologyNature CommunicationsPeer-reviewedJan 7, 2026

Loss of KDM6A-mediated genomic instability and metabolic reprogramming differentially regulates responses to immune checkpoint therapy and chemotherapy in bladder cancer.

Pratishtha Singh, Ranit D’Rozario, Bidisha Chakraborty…·Sangeeta Goswami

This study shows KDM6A mutations in bladder cancer improve response to immune checkpoint therapy but worsen chemotherapy outcomes through effects on DNA repair and metabolic reprogramming.

11 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky